… A recent study by our group identified a panel of acute heart failure-specific miRNAs, in
which decreased miRNA levels were observed in acute heart failure patients compared with …

… present study evaluated the therapeutic potential of H 2 S in murine models of heart failure.
… Therefore, the purpose of the present study was to investigate the potential cardioprotective …

Muscarinic receptors reside in both the atria and ventricles but have a greater density in the
former. 6 They occur more in the endocardium than in the epicardium. Muscarinic receptors …

… Systemic interdependence of heart failure and type 2 diabetes mellitus. In heart failure, …
/or infarction bias towards systolic dysfunction (heart failure with reduced ejection fraction), …

The burden of heart failure with preserved ejection fraction (HFpEF) is considerable and is
projected to worsen. To date, there are no approved therapies available for reducing mortality …

… ECM) provide a potential therapeutic target for prevention of heart failure. This review focuses
on the therapeutic targeting of TGF‐β in the prevention of pathological fibrosis in the heart. …

… Today's science has yet to provide a cure, and there are few therapeutic … heart failure.
There is a critical need to explore new therapeutic approaches in heart failure, and gene therapy …

… The therapeutic potential of MSCs makes them the ideal … for “off the shelf use” potential in
cellular therapeutics; their … to be expanded to sufficient therapeutic quantities ex vivo [3, 7, …

… from adaptive cardiac remodeling to maladaptive remodeling and heart failure. Treatment
strategies for heart failure commonly include diuretics, angiotensin converting enzyme …

… , heart failure is marked by a decrease in cardiac contractility and called systolic heart failure
(3). … Current heart failure therapies rely on two different strategies. The most successful is to …